Cancers co-opt both the immune and cardiovascular systems to fuel their own growth. They do this in part by forming new blood vessels that provide essential nutrients to rapidly dividing cancer cells. T cells in the immune system also use blood vessels as conduits for finding and invading tumors. But vessels in tumors are often abnormal and put up barricades that impede the ability of T cells to locate and kill cancer cells. Now, by using a nanotechnology invented at Vanderbilt University, researchers have discovered that they could reverse the malformed tumor vasculature by activating the stimulator of interferon genes (STING) pathway, a component of the immune system that plays an important role in protecting against pathogen infection and the development of cancers.
An official website of the United States government.